Literature DB >> 33529544

Aerosol Transmission of SARS-CoV-2: Inhalation as well as Exhalation Matters for COVID-19.

Keir E J Philip1,2, Adam Lewis3, Sara C Buttery1,2, Colm McCabe1,2, Daisy Fancourt4, Christopher M Orton1,2, Michael I Polkey1,2, Nicholas S Hopkinson1,2.   

Abstract

Entities:  

Year:  2021        PMID: 33529544      PMCID: PMC8048753          DOI: 10.1164/rccm.202012-4445LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
To the Editor: We read with great interest the article by Echternach and colleagues (1) on the topic of aerosol dispersion during singing and speaking as a potential coronavirus disease (COVID-19) transmission pathway. In the article, as has been the case more broadly regarding this mode of transmission, attention has focused on factors that influence the emission of virus (i.e., aerosol production by the infected individual) when singing or speaking. However, the ventilatory pattern of individuals exposed to the aerosolized virus is also an important factor, as this is likely to be a key modulator of the “dose” of virus-containing aerosol inhaled. As such, the inclusion of such parameters in discussion regarding aerosol transmission is important when considering why certain contexts such as choirs, restaurants, and bars, where speaking, singing, and shouting are common, have been linked to infection clusters (2). Such an appreciation may reframe the discussion to include “superreceptiveness” as a component of “superspreader” events. Ventilatory parameters vary greatly depending on both the type and intensity of activity and should feature more prominently when considering aerosol transmission. We recently investigated the physiological demands of “Singing for Lung Health” in healthy volunteers (3) and found that when participating in the singing component of the protocol, e increased from resting volumes of 11 (9–13) L/min (median, interquartile range [IQR]) to 22.42 L/min (IQR, 16.83–30.54 L/min), and the median volume per breath increased from 0.69 L (IQR, 0.63–0.77 L) to 2.11 L (IQR, 1.92–2.70 L). Other researchers, comparing talking with quiet breathing, found increases in parameters including e, Vt, and breathing frequency (4, 5). Both increased e and increased Vt are likely to be relevant to aerosol transmission. First, the more aerosolized viral particles inhaled the larger the inoculum, which will impact the chance of developing a disease, and may also influence disease severity (6). Second, greater inhalation will increase the alveolar area exposed to virus-containing aerosols, which may have implications for the viral processing and the immune response (7). Considering patterns of inhalation as well as exhalation should enable a more complete appreciation of context-specific viral transmission dynamics. This is particularly relevant to contexts in which e is increased because of physical activity (gyms, supermarkets, etc.) but also where groups of people are vocalizing, such as choral singing, restaurants, bars, and sports crowds. Appreciating these factors does not change the fundamental focus of mitigation measures of hygiene, face coverings, physical distance, and avoiding contexts with poor ventilation. However, given these considerations, particularly with new more infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in circulation, there may now be a stronger argument for face coverings that reduce the risk of inhaling aerosols rather than just reducing their emission, especially in contexts in which people are vocalizing or exercising or other risk factors are present.
  6 in total

1.  Influence of continuous speaking on ventilation.

Authors:  J D Hoit; H L Lohmeier
Journal:  J Speech Lang Hear Res       Date:  2000-10       Impact factor: 2.297

2.  Effects of varied vocal intensity on ventilation and energy expenditure in women and men.

Authors:  B A Russell; F J Cerny; E T Stathopoulos
Journal:  J Speech Lang Hear Res       Date:  1998-04       Impact factor: 2.297

3.  Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.

Authors:  Hin Chu; Jasper Fuk-Woo Chan; Yixin Wang; Terrence Tsz-Tai Yuen; Yue Chai; Yuxin Hou; Huiping Shuai; Dong Yang; Bingjie Hu; Xiner Huang; Xi Zhang; Jian-Piao Cai; Jie Zhou; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Ivy Hau-Yee Chan; Anna Jinxia Zhang; Ko-Yung Sit; Wing-Kuk Au; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

4.  Two metres or one: what is the evidence for physical distancing in covid-19?

Authors:  Nicholas R Jones; Zeshan U Qureshi; Robert J Temple; Jessica P J Larwood; Trisha Greenhalgh; Lydia Bourouiba
Journal:  BMJ       Date:  2020-08-25

5.  Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity.

Authors:  María Pilar Guallar; Rosa Meiriño; Carolina Donat-Vargas; Octavio Corral; Nicolás Jouvé; Vicente Soriano
Journal:  Int J Infect Dis       Date:  2020-06-14       Impact factor: 3.623

6.  Impulse Dispersion of Aerosols during Singing and Speaking: A Potential COVID-19 Transmission Pathway.

Authors:  Matthias Echternach; Sophia Gantner; Gregor Peters; Caroline Westphalen; Tobias Benthaus; Bernhard Jakubaß; Liudmila Kuranova; Michael Döllinger; Stefan Kniesburges
Journal:  Am J Respir Crit Care Med       Date:  2020-12-01       Impact factor: 21.405

  6 in total
  2 in total

1.  Water Transmission Increases the Intensity of COVID-19 Outbreaks.

Authors:  Jianping Huang; Xinbo Lian; Yingjie Zhao; Danfeng Wang; Siyu Chen; Li Zhang; Xiaoyue Liu; Jinfeng Gao; Chuwei Liu
Journal:  Front Public Health       Date:  2022-05-25

2.  A comparison of respiratory particle emission rates at rest and while speaking or exercising.

Authors:  Christopher M Orton; Henry E Symons; Benjamin Moseley; Justice Archer; Natalie A Watson; Keir E J Philip; Sadiyah Sheikh; Brian Saccente-Kennedy; Declan Costello; William J Browne; James D Calder; Bryan R Bzdek; James H Hull; Jonathan P Reid; Pallav L Shah
Journal:  Commun Med (Lond)       Date:  2022-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.